Literature DB >> 25438997

Mechanism of action of immunotherapy.

Mary L Disis1.   

Abstract

The immune system plays a vital role in regulating the growth of tumors. Some types of inflammatory responses can promote tumor growth, while a tumor-specific adaptive immune response can potentially control tumor growth. Malignancies have the ability to evade the immune system, and proliferate and metastasize. The goal of immunotherapy is to marshal the specificity and long-term memory of the adaptive immune response to achieve durable tumor regression and possible cure, although, to date, this has been achieved in only a small subset of patients. A variety of approaches to immunotherapy have been investigated. These include administration of exogenous cytokines or therapeutic vaccines to increase the frequency of tumor-specific T cells, adoptive transfer of tumor-specific immune effector cells, and, more recently, the application of a variety of immune checkpoint inhibitors and agonists of co-stimulatory receptors to overcome tumor-induced immune-suppressive mechanisms. Some approaches have been more successful than others for reasons that are now becoming apparent, and these observations have led to an exciting resurgence in clinical research to develop more effective immunotherapeutic strategies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25438997     DOI: 10.1053/j.seminoncol.2014.09.004

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  39 in total

Review 1.  Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios.

Authors:  Rebecca Tay; Arsela Prelaj; Raffaele Califano
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  From the Guest Editor: The Rapidly Changing Field of Cancer Treatment.

Authors:  Robert A Ramirez
Journal:  Ochsner J       Date:  2017

Review 3.  Immunotherapy in treatment naïve advanced non-small cell lung cancer.

Authors:  Vinicius Ernani; Apar Kishor Ganti
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

4.  Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Authors:  Andrea M Patterson; Saghar Kaabinejadian; Curtis P McMurtrey; Wilfried Bardet; Ken W Jackson; Rosemary E Zuna; Sanam Husain; Gregory P Adams; Glen MacDonald; Rachelle L Dillon; Harold Ames; Rico Buchli; Oriana E Hawkins; Jon A Weidanz; William H Hildebrand
Journal:  Mol Cancer Ther       Date:  2015-12-30       Impact factor: 6.261

5.  A new therapeutic potential for cancers: One CAR with 2 different engines!

Authors:  Abdolkarim Sheikhi; Abdollah Jafarzadeh
Journal:  Hum Vaccin Immunother       Date:  2017-05-11       Impact factor: 3.452

Review 6.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

Review 7.  Immune checkpoint pathways in non-small cell lung cancer.

Authors:  Young Kwang Chae; Ayush Arya; Wade Iams; Marcello Cruz; Nisha Mohindra; Victoria Villaflor; Francis J Giles
Journal:  Ann Transl Med       Date:  2018-03

Review 8.  [Immunological tumor therapy].

Authors:  K Dietrich; M Theobald
Journal:  Internist (Berl)       Date:  2015-08       Impact factor: 0.743

Review 9.  Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials.

Authors:  Alessandro Paniccia; Justin Merkow; Barish H Edil; Yuwen Zhu
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

Review 10.  T cell receptor mimic antibodies for cancer therapy.

Authors:  Leonid Dubrovsky; Tao Dao; Ron S Gejman; Elliott J Brea; Aaron Y Chang; Claire Y Oh; Emily Casey; Dmitry Pankov; David A Scheinberg
Journal:  Oncoimmunology       Date:  2015-06-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.